BioMap is a leading life science AI company founded in 2020 by Baidu hat revolutionizes drug discovery through its xTrimo foundation model system—the world's largest life science AI foundation model with 2.1 trillion parameters trained on over 6 billion proteins, 100 billion protein-protein interactions, and trillions of single-cell gene expression measurements. The company's AIDD (AI-Driven Drug Discovery) services leverage more than 25 specialized task models to enable pharmaceutical and biotechnology organizations to solve complex drug discovery challenges, including therapeutic antibody design through its ImmuBot® platform, industrial enzyme development, and de novo protein engineering. With approximately 1,000 global clients and strategic partnerships including a billion-dollar collaboration with Sanofi, BioMap operates cutting-edge high-throughput wet labs and world-leading supercomputing infrastructure to accelerate the discovery of novel therapeutic molecules and proteins.